Matches in Nanopublications for { ?s ?p "[Aberrant expression of CD2, CD3, and/or CD5 antigens was noted in 3 of 6 (50%) cases of patch/plaque-stage MF, all three cases of tumor-stage MF, and 5 of 8 (62%) pleomorphic CTCLs, but not in any of the 11 pseudo-T-cell lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP937699.RAiyJuEfI487wdZkFAESG323sfz5p3myfDWS15pptlYxI130_assertion description "[Aberrant expression of CD2, CD3, and/or CD5 antigens was noted in 3 of 6 (50%) cases of patch/plaque-stage MF, all three cases of tumor-stage MF, and 5 of 8 (62%) pleomorphic CTCLs, but not in any of the 11 pseudo-T-cell lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP937699.RAiyJuEfI487wdZkFAESG323sfz5p3myfDWS15pptlYxI130_provenance.
- NP584834.RAkkWl2t4IYELwINyqbIQ1B-9dHwiIpsSpaJ9xs7R83W8130_assertion description "[Aberrant expression of CD2, CD3, and/or CD5 antigens was noted in 3 of 6 (50%) cases of patch/plaque-stage MF, all three cases of tumor-stage MF, and 5 of 8 (62%) pleomorphic CTCLs, but not in any of the 11 pseudo-T-cell lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584834.RAkkWl2t4IYELwINyqbIQ1B-9dHwiIpsSpaJ9xs7R83W8130_provenance.
- NP670533.RAg3A7hD2tUGey5-iBBUMHWNMeDHV2__lyUXxsOvYOHtg130_assertion description "[Aberrant expression of CD2, CD3, and/or CD5 antigens was noted in 3 of 6 (50%) cases of patch/plaque-stage MF, all three cases of tumor-stage MF, and 5 of 8 (62%) pleomorphic CTCLs, but not in any of the 11 pseudo-T-cell lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP670533.RAg3A7hD2tUGey5-iBBUMHWNMeDHV2__lyUXxsOvYOHtg130_provenance.
- NP783689.RAefCxOHUUvZMvUbArVENnWrD42c9VQQ9BTQux9o9HE7w130_assertion description "[Aberrant expression of CD2, CD3, and/or CD5 antigens was noted in 3 of 6 (50%) cases of patch/plaque-stage MF, all three cases of tumor-stage MF, and 5 of 8 (62%) pleomorphic CTCLs, but not in any of the 11 pseudo-T-cell lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783689.RAefCxOHUUvZMvUbArVENnWrD42c9VQQ9BTQux9o9HE7w130_provenance.
- NP871892.RAWEhXjqt567Pw1BXYImjHK7I1C2O6JIocXGwsRa38HCc130_assertion description "[Aberrant expression of CD2, CD3, and/or CD5 antigens was noted in 3 of 6 (50%) cases of patch/plaque-stage MF, all three cases of tumor-stage MF, and 5 of 8 (62%) pleomorphic CTCLs, but not in any of the 11 pseudo-T-cell lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP871892.RAWEhXjqt567Pw1BXYImjHK7I1C2O6JIocXGwsRa38HCc130_provenance.
- NP789541.RAEXXfXXgyoeO4ZYlUQHa8SQUM5OJKaYAyjird_JUaxoY130_assertion description "[Aberrant expression of CD2, CD3, and/or CD5 antigens was noted in 3 of 6 (50%) cases of patch/plaque-stage MF, all three cases of tumor-stage MF, and 5 of 8 (62%) pleomorphic CTCLs, but not in any of the 11 pseudo-T-cell lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789541.RAEXXfXXgyoeO4ZYlUQHa8SQUM5OJKaYAyjird_JUaxoY130_provenance.